It also underscores the pivotal role of myeloid cells in the pathogenesis of autoimmune encephalitis, suggesting that TLR2 could serve as a potential therapeutic target to dampen this positive feedback cascade, thereby mitigating disease progression or aiding the efficacy of other treatment modalities. The gene discussed is TLR2; the disease is autoimmune encephalitis.